Biotech · Private company
HiFiBiO Therapeutics
Track this companyFree. Adds HiFiBiO Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- HFB200301Phase 1 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
- HFB200603Phase 1 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- HFB301001Phase 1 · Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- HFB30132APhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TislelizumabPhase 1 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
- TislelizumabPhase 1 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started May 9, 2023ClinicalTrials.gov NCT05789069 · fetched Nov 12, 2026
- A Study of HFB301001 in Adult Patients With Advanced Solid TumorsPHASE1 · TERMINATED · started Apr 20, 2022ClinicalTrials.gov NCT05229601 · fetched Nov 12, 2026
- A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 10, 2022ClinicalTrials.gov NCT05238883 · fetched Nov 12, 2026
- Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy AdultsPHASE1 · COMPLETED · started Oct 20, 2020ClinicalTrials.gov NCT04590430 · fetched Nov 12, 2026